Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis of a drug-coated balloon
PA Schneider, JR Laird, G Doros, Q Gao… - Journal of the American …, 2019 - jacc.org
Background: Five years of prospective clinical trials confirm that the paclitaxel drug-coated
balloon (DCB)(IN. PACT Admiral, Medtronic, Dublin, Ireland) is safe and effective to treat …
balloon (DCB)(IN. PACT Admiral, Medtronic, Dublin, Ireland) is safe and effective to treat …
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials
F Costa, C Montalto, M Branca, SJ Hong… - European Heart …, 2023 - academic.oup.com
Aims The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary
intervention (PCI) in patients at high bleeding risk (HBR) is still debated. The current study …
intervention (PCI) in patients at high bleeding risk (HBR) is still debated. The current study …
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral …
… by: the European Stroke Organisation (ESO … - European heart …, 2011 - academic.oup.com
Cardiovascular diseases (CVDs) are the leading cause of death and disability in Europe,
posing a great social and economic burden. Coronary artery disease (CAD) is the cause of …
posing a great social and economic burden. Coronary artery disease (CAD) is the cause of …
Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month …
G Tepe, J Laird, P Schneider, M Brodmann… - Circulation, 2015 - Am Heart Assoc
Background—Drug-coated balloons (DCBs) have shown promise in improving the
outcomes for patients with peripheral artery disease. We compared a paclitaxel-coated …
outcomes for patients with peripheral artery disease. We compared a paclitaxel-coated …
A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and …
A Latib, A Colombo, F Castriota, A Micari… - Journal of the American …, 2012 - jacc.org
Objectives: The aim of this study was to evaluate the efficacy of drug-eluting balloons (DEB)
compared with paclitaxel-eluting stents (PES) for the reduction of restenosis in small …
compared with paclitaxel-eluting stents (PES) for the reduction of restenosis in small …
Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN. PACT …
T Zeller, I Baumgartner, D Scheinert… - Journal of the American …, 2014 - jacc.org
Background: Drug-eluting balloons (DEB) may reduce infrapopliteal restenosis and
reintervention rates versus percutaneous transluminal angioplasty (PTA) and improve …
reintervention rates versus percutaneous transluminal angioplasty (PTA) and improve …
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year …
Summary Background The Minimizing Adverse Haemorrhagic Events by Transradial Access
Site and Systemic Implementation of Angiox (MATRIX) programme was designed to assess …
Site and Systemic Implementation of Angiox (MATRIX) programme was designed to assess …
Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN. PACT SFA
JR Laird, PA Schneider, G Tepe, M Brodmann… - Journal of the American …, 2015 - jacc.org
Background: Evidence from large, randomized, controlled peripheral artery disease trials
reporting long-term outcomes using drug-coated balloons (DCBs) is limited. Previously, the …
reporting long-term outcomes using drug-coated balloons (DCBs) is limited. Previously, the …
[HTML][HTML] Clinical outcomes of second-versus first-generation carotid stents: a systematic review and meta-analysis
A Mazurek, K Malinowski, K Rosenfield… - Journal of Clinical …, 2022 - mdpi.com
Background: Single-cohort studies suggest that second-generation stents (SGS;“mesh
stents”) may improve carotid artery stenting (CAS) outcomes by limiting peri-and …
stents”) may improve carotid artery stenting (CAS) outcomes by limiting peri-and …
Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN. PACT SFA randomized trial
PA Schneider, JR Laird, G Tepe… - Circulation …, 2018 - Am Heart Assoc
Background—Randomized controlled trials have reported favorable 1-year outcomes with
drug-coated balloons (DCBs) for the treatment of symptomatic peripheral arterial disease …
drug-coated balloons (DCBs) for the treatment of symptomatic peripheral arterial disease …